Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study) (Q28199833)

2

0 references

Davor Milicić

3

0 references

Mijo Bergovec

4

0 references

Danijel Planinc

European Journal of Cardiovascular Prevention and Rehabilitation

5

0 references

language of work or name

English

0 references

publication date

August 2006

0 references

published in

0 references

volume

13

0 references

issue

4

0 references

page(s)

646-54

0 references

cites work

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000183910.59741.96

Selected major risk factors and global and regional burden of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000183910.59741.96

Prevalence of conventional risk factors in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000183910.59741.96

Acute myocardial infarction among civilians in Zagreb city area

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000183910.59741.96

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000183910.59741.96

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000183910.59741.96

beta Blockade after myocardial infarction: systematic review and meta regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000183910.59741.96

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000183910.59741.96

Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000183910.59741.96

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000183910.59741.96

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000183910.59741.96

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000183910.59741.96

Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000183910.59741.96

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000183910.59741.96

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000183910.59741.96